<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font18 { font-size : 18; } .font19 { font-size : 19; } .font20 { font-size : 20; } .font22 { font-size : 22; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font29 { font-size : 29; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font29">and </span>
   <span class="font22">with </span>
   <span class="font20">(). </span>
   <span class="font19">patients </span>
   <span class="font18">COVID- </span>
   <span class="font16">:â€". </span>
   <span class="font14">for </span>
   <span class="font14">al.. </span>
   <span class="font13">kidney </span>
   <span class="font13">that </span>
   <span class="font13">disease </span>
   <span class="font13">The </span>
   <span class="font13">SARS-CoV- </span>
   <span class="font13">severe </span>
   <span class="font12">are </span>
   <span class="font12">study </span>
   <span class="font12">clinical </span>
   <span class="font12">coronavirus </span>
   <span class="font12">not </span>
   <span class="font12">virus </span>
   <span class="font12">{background </span>
   <span class="font12">Kidney </span>
   <span class="font11">Med. </span>
   <span class="font11">acute </span>
   <span class="font11">have </span>
   <span class="font11">treatment </span>
   <span class="font11">has </span>
   <span class="font11">infection </span>
   <span class="font11">risk </span>
   <span class="font11">viral </span>
   <span class="font11">was </span>
   <span class="font11">may </span>
   <span class="font11">respiratory </span>
   <span class="font11">trials </span>
   <span class="font11">could </span>
   <span class="font11">from </span>
   <span class="font11">patients, </span>
   <span class="font11">retrospective </span>
   <span class="font11">transplant </span>
   <span class="font11">margin </span>
   <span class="font11">AKI </span>
   <span class="font11">associated </span>
   <span class="font11">been </span>
   <span class="font11">{border-style </span>
   <span class="font11">Engl </span>
   <span class="font11">cells </span>
   <span class="font11">infected </span>
   <span class="font11">showed </span>
   <span class="font11">[Epub </span>
   <span class="font11">ahead </span>
   <span class="font11">print]. </span>
   <span class="font11">px;} </span>
   <span class="font11">use </span>
   <span class="font11">#ffffff;} </span>
   <span class="font11">COVID-. </span>
   <span class="font11">mortality </span>
   <span class="font11">other </span>
   <span class="font11">should </span>
   <span class="font11">pneumonia </span>
   <span class="font11">these </span>
   <span class="font11">Ongoing </span>
   <span class="font11">during </span>
   <span class="font11">but </span>
   <span class="font11">compared </span>
   <span class="font11">increased </span>
   <span class="font11">patients. </span>
   <span class="font11">were </span>
   <span class="font10">also </span>
   <span class="font10">being </span>
   <span class="font10">can </span>
   <span class="font10">cell </span>
   <span class="font10">drugs </span>
   <span class="font10">found </span>
   <span class="font10">had </span>
   <span class="font10">higher </span>
   <span class="font10">one </span>
   <span class="font10">syndrome </span>
   <span class="font10">therapy </span>
   <span class="font10">ACE </span>
   <span class="font10">However, </span>
   <span class="font10">Wuhan, </span>
   <span class="font10">al. </span>
   <span class="font10">case </span>
   <span class="font10">dialysis </span>
   <span class="font10">improvement </span>
   <span class="font10">inhibitor </span>
   <span class="font10">lung </span>
   <span class="font10">those </span>
   <span class="font10">treated </span>
   <span class="font10">./S-()- </span>
   <span class="font10">Nephrol. </span>
   <span class="font10">RNA </span>
   <span class="font10">against </span>
   <span class="font10">anti-inflammatory </span>
   <span class="font10">injury </span>
   <span class="font10">ongoing </span>
   <span class="font10">receptor </span>
   <span class="font10">studies </span>
   <span class="font10">this </span>
   <span class="font10">through </span>
   <span class="font10">./.... </span>
   <span class="font10">COVID-: </span>
   <span class="font10">China. </span>
   <span class="font10">complement </span>
   <span class="font10">data </span>
   <span class="font10">individuals </span>
   <span class="font10">inflammatory </span>
   <span class="font10">inhibitors </span>
   <span class="font10">medRxiv. </span>
   <span class="font10">more </span>
   <span class="font10">protease </span>
   <span class="font10">response </span>
   <span class="font10">tested </span>
   <span class="font10">trial </span>
   <span class="font10">who </span>
   <span class="font10">./NEJMoa </span>
   <span class="font10">./j.kint... </span>
   <span class="font10">./s--- </span>
   <span class="font10">COVID-, </span>
   <span class="font10">Int. </span>
   <span class="font10">approved </span>
   <span class="font10">because </span>
   <span class="font10">cases </span>
   <span class="font10">damage </span>
   <span class="font10">efficacy </span>
   <span class="font10">its </span>
   <span class="font10">novel </span>
   <span class="font10">plasma </span>
   <span class="font10">potential </span>
   <span class="font10">randomized </span>
   <span class="font10">which </span>
   <span class="font10">(not </span>
   <span class="font10">Clinical </span>
   <span class="font10">Covid-. </span>
   <span class="font10">IL- </span>
   <span class="font10">Patients </span>
   <span class="font10">This </span>
   <span class="font10">Transplant. </span>
   <span class="font10">activity </span>
   <span class="font10">antiviral </span>
   <span class="font10">between </span>
   <span class="font10">chronic </span>
   <span class="font10">considered </span>
   <span class="font10">death </span>
   <span class="font10">disease, </span>
   <span class="font10">effects </span>
   <span class="font10">hospitalized </span>
   <span class="font10">host </span>
   <span class="font10">immune </span>
   <span class="font10">infection, </span>
   <span class="font10">peer-reviewed) </span>
   <span class="font10">px; </span>
   <span class="font10">rate </span>
   <span class="font10">renal </span>
   <span class="font10">report </span>
   <span class="font10">reported </span>
   <span class="font10">several </span>
   <span class="font10">symptoms </span>
   <span class="font10">system </span>
   <span class="font10">than </span>
   <span class="font10">when </span>
   <span class="font10">without </span>
   <span class="font10">{font-family </span>
   <span class="font10">Int </span>
   <span class="font10">SARS-CoV-. </span>
   <span class="font10">Soc </span>
   <span class="font10">activation </span>
   <span class="font10">both </span>
   <span class="font10">font-size </span>
   <span class="font10">hemodialysis </span>
   <span class="font10">like </span>
   <span class="font10">observational </span>
   <span class="font10">presented </span>
   <span class="font10">protein </span>
   <span class="font10">significant </span>
   <span class="font10">stage </span>
   <span class="font10">tissue </span>
   <span class="font10">treat </span>
   <span class="font10">uncontrolled </span>
   <span class="font10">(accessed </span>
   <span class="font10">.Available, </span>
   <span class="font10">During </span>
   <span class="font10">Lancet </span>
   <span class="font10">Lancet. </span>
   <span class="font10">SARS-CoV </span>
   <span class="font10">another </span>
   <span class="font10">at: </span>
   <span class="font10">care </span>
   <span class="font10">characteristics </span>
   <span class="font10">common </span>
   <span class="font10">convalescent </span>
   <span class="font10">countries </span>
   <span class="font10">currently </span>
   <span class="font10">did </span>
   <span class="font10">double; </span>
   <span class="font10">especially </span>
   <span class="font10">expression </span>
   <span class="font10">factor </span>
   <span class="font10">factors </span>
   <span class="font10">function </span>
   <span class="font10">high </span>
   <span class="font10">hydroxychloroquine </span>
   <span class="font10">impact </span>
   <span class="font10">incidence </span>
   <span class="font10">including </span>
   <span class="font10">induced </span>
   <span class="font10">levels </span>
   <span class="font10">monoclonal </span>
   <span class="font10">online </span>
   <span class="font10">patient </span>
   <span class="font10">recovery </span>
   <span class="font10">safety </span>
   <span class="font10">study. </span>
   <span class="font10">they </span>
   <span class="font10">time </span>
   <span class="font10">used </span>
   <span class="font10">while </span>
   <span class="font10">(COVID-) </span>
   <span class="font10">./ajt. </span>
   <span class="font10">D-dimer </span>
   <span class="font10">Dis. </span>
   <span class="font10">IL-, </span>
   <span class="font10">Med </span>
   <span class="font10">Preliminary </span>
   <span class="font10">RCT </span>
   <span class="font10">Remdesivir </span>
   <span class="font10">Renal </span>
   <span class="font10">There </span>
   <span class="font10">Therefore, </span>
   <span class="font10">These </span>
   <span class="font10">about </span>
   <span class="font10">after </span>
   <span class="font10">among </span>
   <span class="font10">binding </span>
   <span class="font10">blocking </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">controlled </span>
   <span class="font10">current </span>
   <span class="font10">directly </span>
   <span class="font10">distress </span>
   <span class="font10">drug </span>
   <span class="font10">elevated </span>
   <span class="font10">enter </span>
   <span class="font10">entry </span>
   <span class="font10">epidemic </span>
   <span class="font10">first </span>
   <span class="font10">ill </span>
   <span class="font10">immunosuppression </span>
   <span class="font10">infection. </span>
   <span class="font10">involvement </span>
   <span class="font10">lead </span>
   <span class="font10">management </span>
   <span class="font10">many </span>
   <span class="font10">mild </span>
   <span class="font10">most </span>
   <span class="font10">often </span>
   <span class="font10">outcome </span>
   <span class="font10">outcomes </span>
   <span class="font10">pathogenesis </span>
   <span class="font10">population </span>
   <span class="font10">present </span>
   <span class="font10">prevent </span>
   <span class="font10">pulmonary </span>
   <span class="font10">received </span>
   <span class="font10">reduction </span>
   <span class="font10">remdesivir </span>
   <span class="font10">results </span>
   <span class="font10">serine </span>
   <span class="font10">severity </span>
   <span class="font10">solid; </span>
   <span class="font10">spike </span>
   <span class="font10">stem </span>
   <span class="font10">their </span>
   <span class="font10">there </span>
   <span class="font10">trial. </span>
   <span class="font10">withdrawal </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(), </span>
   <span class="font10">./ASN. </span>
   <span class="font10">./NEJMc </span>
   <span class="font10">ACE, </span>
   <span class="font10">Anakinra </span>
   <span class="font10">Camostat </span>
   <span class="font10">China </span>
   <span class="font10">China: </span>
   <span class="font10">Chronic </span>
   <span class="font10">Clin </span>
   <span class="font10">Complement </span>
   <span class="font10">Disease </span>
   <span class="font10">Favipiravir </span>
   <span class="font10">Infect. </span>
   <span class="font10">Moreover, </span>
   <span class="font10">Nat </span>
   <span class="font10">One </span>
   <span class="font10">RAS </span>
   <span class="font10">Respir </span>
   <span class="font10">Rev </span>
   <span class="font10">TMPRSS </span>
   <span class="font10">Transplant </span>
   <span class="font10">Treatment </span>
   <span class="font10">absence </span>
   <span class="font10">affected </span>
   <span class="font10">agents </span>
   <span class="font10">already </span>
   <span class="font10">angiotensin </span>
   <span class="font10">any </span>
   <span class="font10">areas </span>
   <span class="font10">article </span>
   <span class="font10">asymptomatic </span>
   <span class="font10">authors </span>
   <span class="font10">benefit </span>
   <span class="font10">blood </span>
   <span class="font10">bold </span>
   <span class="font10">cells, </span>
   <span class="font10">cellular </span>
   <span class="font10">center </span>
   <span class="font10">coagulation </span>
   <span class="font10">complications </span>
   <span class="font10">cough, </span>
   <span class="font10">courier; </span>
   <span class="font10">creatinine </span>
   <span class="font10">critically </span>
   <span class="font10">cytokine </span>
   <span class="font10">decreased </span>
   <span class="font10">demonstrated </span>
   <span class="font10">difference </span>
   <span class="font10">direct </span>
   <span class="font10">does </span>
   <span class="font10">donor </span>
   <span class="font10">drugs, </span>
   <span class="font10">due </span>
   <span class="font10">early </span>
   <span class="font10">em; </span>
   <span class="font10">endosomal </span>
   <span class="font10">endothelial </span>
   <span class="font10">enzyme </span>
   <span class="font10">even </span>
   <span class="font10">evidence </span>
   <span class="font10">fever, </span>
   <span class="font10">findings </span>
   <span class="font10">general </span>
   <span class="font10">group </span>
   <span class="font10">heparin </span>
   <span class="font10">highly </span>
   <span class="font10">human </span>
   <span class="font10">improved </span>
   <span class="font10">increases </span>
   <span class="font10">induce </span>
   <span class="font10">infections </span>
   <span class="font10">inflammation, </span>
   <span class="font10">inhibit </span>
   <span class="font10">initial </span>
   <span class="font10">into </span>
   <span class="font10">kidneys </span>
   <span class="font10">known </span>
   <span class="font10">least </span>
   <span class="font10">long-term </span>
   <span class="font10">lower </span>
   <span class="font10">markers </span>
   <span class="font10">mesenchymal </span>
   <span class="font10">multiple </span>
   <span class="font10">necrosis </span>
   <span class="font10">new </span>
   <span class="font10">observed </span>
   <span class="font10">organ </span>
   <span class="font10">outbreak </span>
   <span class="font10">over </span>
   <span class="font10">pandemic </span>
   <span class="font10">pneumonia. </span>
   <span class="font10">polymerase </span>
   <span class="font10">positive </span>
   <span class="font10">pt;} </span>
   <span class="font10">reduce </span>
   <span class="font10">related </span>
   <span class="font10">replacement </span>
   <span class="font10">replication </span>
   <span class="font10">requiring </span>
   <span class="font10">respectively) </span>
   <span class="font10">series </span>
   <span class="font10">show </span>
   <span class="font10">significantly </span>
   <span class="font10">some </span>
   <span class="font10">specific </span>
   <span class="font10">spread </span>
   <span class="font10">standard </span>
   <span class="font10">storm </span>
   <span class="font10">testing </span>
   <span class="font10">tract </span>
   <span class="font10">tubular </span>
   <span class="font10">two </span>
   <span class="font10">under </span>
   <span class="font10">virus. </span>
   <span class="font10">â€" </span>
  </p>
 </body>
</html>
